Treatment Outcomes of FluoroquinoloneResistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid

被引:1
作者
Putra, Oki Nugraha [1 ,3 ]
Purnamasari, Telly [2 ]
机构
[1] Hang Tuah Univ, Fac Med, Study Program Pharm, Dept Clin & Community Pharm, Surabaya, Indonesia
[2] Natl Res & Innovat Agcy, Preclin & Clin Studies, Cent Jakarta, Indonesia
[3] Hang Tuah Univ, Fac Med, Study Program Pharm, Dept Clin & Community Pharm, Arief Rahman Hakim 150, Surabaya, East Java, Indonesia
关键词
LEVOFLOXACIN; BEDAQUILINE;
D O I
10.4046/trd.2023.0188
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:206 / 208
页数:3
相关论文
共 12 条
[1]   Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection [J].
Al-Shaer, Mohammad H. ;
Alghamdi, Wael A. ;
Alsultan, Abdullah ;
An, Guohua ;
Ahmed, Shahriar ;
Alkabab, Yosra ;
Banu, Sayera ;
Barbakadze, Ketevan ;
Houpt, Eric ;
Kipiani, Maia ;
Mikiashvili, Lali ;
Cegielski, J. Peter ;
Kempker, Russell R. ;
Heysell, Scott K. ;
Peloquin, Charles A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)
[2]   Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016 [J].
Bhering, Marcela ;
Duarte, Raquel ;
Kritski, Afranio .
PLOS ONE, 2019, 14 (11)
[3]   Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching [J].
Choi, Hongjo ;
Jeong, Dawoon ;
Kang, Young Ae ;
Jeon, Doosoo ;
Kang, Hee-Yeon ;
Kim, Hee Jin ;
Kim, Hee-Sun ;
Mok, Jeongha .
TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (03) :234-244
[4]   Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid [J].
Hwang, Hyeontaek ;
Kang, Hyungseok ;
Kwon, Yong-Soo ;
Jeon, Doosoo ;
Shim, Tae Sun ;
Yim, Jae-Joon .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (08) :1362-1369
[5]   Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea [J].
Kang, Hyungseok ;
Jo, Kyung-Wook ;
Jeon, Doosoo ;
Yim, Jae-Joon ;
Shim, Tae Sun .
RESPIRATORY MEDICINE, 2020, 167
[6]   Cavitary Penetration of Levofloxacin among Patients with Multidrug-Resistant Tuberculosis [J].
Kempker, Russell R. ;
Barth, Aline B. ;
Vashakidze, Sergo ;
Nikolaishvili, Ketino ;
Sabulua, Irina ;
Tukvadze, Nestani ;
Bablishvili, Nino ;
Gogishvili, Shota ;
Singh, Ravi Shankar P. ;
Guarner, Jeannette ;
Derendorf, Hartmut ;
Peloquin, Charles A. ;
Blumberg, Henry M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) :3149-3155
[7]  
Lestari BW, 2023, Lancet Reg Health Southeast Asia
[8]   9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea [J].
Mok, Jeongha ;
Lee, Myungsun ;
Kim, Deog Kyeom ;
Kim, Ju Sang ;
Jhun, Byung Woo ;
Jo, Kyung-Wook ;
Jeon, Doosoo ;
Lee, Taehoon ;
Lee, Ji Yeon ;
Park, Jae Seuk ;
Lee, Seung Heon ;
Kang, Young Ae ;
Lee, Jung-Kyu ;
Kwak, Nakwon ;
Ahn, Joong Hyun ;
Shim, Tae Sun ;
Kim, Song Yee ;
Kim, Seungmo ;
Kim, Kyungjong ;
Seok, Kwang-Hyuk ;
Yoon, Soyeong ;
Kim, Young Ran ;
Kim, Jisu ;
Yim, Dahae ;
Hahn, Seokyung ;
Cho, Sang Nae ;
Yim, Jae-Joon .
LANCET, 2022, 400 (10362) :1522-1530
[9]   Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review [J].
Putra, Oki ;
Yulistiani, Yulistiani ;
Soedarsono, Soedarsono ;
Subay, Susi .
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2023, 12 (01) :1-9
[10]   Evaluation of risk factors associated with the development of MDR- and XDR-TB in a tertiary care hospital: a retrospective cohort study [J].
Saifullah, Amna ;
Mallhi, Tauqeer Hussain ;
Khan, Yusra Habib ;
Iqbal, Muhammad Shahid ;
Alotaibi, Nasser Hadal ;
Alzarea, Abdulaziz Ibrahim ;
Rasheed, Maria .
PEERJ, 2021, 9